Michael Davies, CEO of Global Health caught up with Ky Chow from Proactive Investors to discuss the company's latest 4C Quarterly results. Michael discusses the growth in our sales pipeline, the steps we are taking to re-platform and revolutionise our R&D, our successful implementation of...
Listen to CEO Michael Davies as he provides an update six months into his new role. Learn how Michael is leading the team, leveraging sales and marketing capabilities, investing in research and development, and positioning our product portfolio for growth. The update includes information on...
Global Health’s CEO Michael Davies talks to Proactive Investors about the company’s main mission; to deliver healthcare software for clinicians, community health organisations and administrators at the more complex end of the market. Watch the video.
Luke Winchester from Merewether Capital reviews how Global Health grew its revenue by 25% despite COVID-19 limitations in FY21 and how it’s best-in-class product is set to disrupt the market. Watch the full video.
Listen to Michael Davies as he provides an updated investor presentation, 90 days into his tenure as Global Health's new CEO. Watch the video.
Global Health's Executive Director and former CEO, Mathew Cherian, presented at the Proactive Lifesciences investor webinar earlier today to show off the company's latest investor presentation.
Mathew Cherian, Managing Director of Global Health, appeared for an interview last week with The Market Herald's "Deal Room" to discuss the recent appointment of Michael Davies as CEO and the subsequent trading halt which took place on June 10.
